Live Breaking News & Updates on Slattery Jr|Page 2

Stay updated with breaking news from Slattery jr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ChemoCentryx Announces Appoint - GuruFocus.com

GuruFocus Article or News written by PurpleRose and the topic is about: ....

United States , Stephanie Tomei , Slattery Jr , Jenniferl Herron , Bristol Myers Squibb , Thomasj Schall , Exchange Commission , Lehigh University , Georgetown University , Ariad Pharmaceuticals As Executive Vice , Corporate Communications , Chemocentryx Inc , Chief Executive Officer , Senior Vice President , Chief Commercial Officer , Executive Vice President , Global Commercial , Ariad Pharmaceuticals , Novartis Oncology , Smithkline Beecham Oncology , Full Prescribing Information , Medication Guide , Annual Report , Private Securities Litigation Reform Act ,

2022-07-05 | NDAQ:CCXI | Press Release | ChemoCentryx Inc.

(2022-07-05 | NDAQ:CCXI) ChemoCentryx Announces Appointment of Jennifer L. Herron to Board as Independent Director ....

United States , Stephanie Tomei , Jennifer Closecurlyquote , Slattery Jr , Jenniferl Herron , Bristol Myers Squibb , Thomasj Schall , Ariad Pharmaceuticals As Executive Vice , Exchange Commission , Lehigh University , Georgetown University , Corporate Communications , Chemocentryx Inc , Chief Executive Officer , Senior Vice President , Chief Commercial Officer , Executive Vice President , Global Commercial , Ariad Pharmaceuticals , Novartis Oncology , Smithkline Beecham Oncology , Full Prescribing Information , Medication Guide , Annual Report , Private Securities Litigation Reform Act , Investor Relations ,

ChemoCentryx Announces Appointment of Jennifer L. Herron to Board as Independent Director

SAN CARLOS, Calif., July 05, 2022 (GLOBE NEWSWIRE) ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Jennifer L. Herron has been appointed to the Board as an independent director, effective ....

United States , Stephanie Tomei , Slattery Jr , Jenniferl Herron , Bristol Myers Squibb , Thomasj Schall , Ariad Pharmaceuticals As Executive Vice , Exchange Commission , Lehigh University , Georgetown University , Chemocentryx Inc , Investor Relations Corporate Communications , Chief Executive Officer , Senior Vice President , Chief Commercial Officer , Executive Vice President , Global Commercial , Ariad Pharmaceuticals , Novartis Oncology , Smithkline Beecham Oncology , Full Prescribing Information , Medication Guide , Annual Report , Private Securities Litigation Reform Act , Bill Slattery , Vice President ,

ChemoCentryx Announces Changes - GuruFocus.com

GuruFocus Article or News written by GuruFocusNews and the topic is about: ....

United States , Harvard University , Stephanie Tomei , Slattery Jr , Davide Wheadon , Henrya Mckinnell Jr , Hank Mckinnell , Thomasj Schall , Regulatory Affairs At Ph , Karuna Therapeutics Inc , Washingtond Pharmaceutical Industry Research , Diabetes Research Foundation , Department Of Health , National Institutes Of Health , Human Services , Us Regulatory Affairs At Glaxosmithkline Laboratories , Drug Administration , Johns Hopkins University School Of Medicine , Sotera Health Company , Exchange Commission , Manufacturers Association , Sciences At Abbott Laboratories , Corporate Communications , Vaxart Inc , Global Regulatory Affairs , Chemocentryx Inc ,

ChemoCentryx Announces Changes to its Board of Directors

David E. Wheadon, M.D., Elected to the Board as an Independent Director Henry A. McKinnell, Jr., to Retire from Board SAN CARLOS, Calif., May. ....

United States , Harvard University , Stephanie Tomei , Slattery Jr , Davide Wheadon , Henrya Mckinnell Jr , Hank Mckinnell , Thomasj Schall , Regulatory Affairs At Ph , Washingtond Pharmaceutical Industry Research , Diabetes Research Foundation , Therapeutics Inc , Department Of Health , National Institutes Of Health , Human Services , Us Regulatory Affairs At Glaxosmithkline Laboratories , Drug Administration , Johns Hopkins University School Of Medicine , Sotera Health Company , Exchange Commission , Manufacturers Association , Sciences At Abbott Laboratories , Corporate Communications , Vaxart Inc , Global Regulatory Affairs , Chemocentryx Inc ,